(BDCX) ETRACS Quarterly Pay 1.5X - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US90269A2603 • Trading--Leveraged Equity

BDCX: BDC Index, Leveraged, ETN, Investments

The ETRACS Quarterly Pay 1.5X Leveraged Wells Fargo BDC Index ETN (BDCX) is designed to provide leveraged exposure to the performance of Business Development Companies (BDCs) listed on major U.S. exchanges, including the NYSE, NYSE AMEX, and NASDAQ. The underlying Wells Fargo BDC Index is a proprietary index developed by Wells Fargo Securities, LLC, and includes BDCs that meet specific market capitalization and eligibility criteria. BDCs are specialized financial institutions that primarily invest in and lend to middle-market businesses.

Ticker Symbol: BDCX Exchange: NYSE ARCA Type: ETN Country Origin: USA ETF Category: Trading--Leveraged Equity

As of the latest data, the ETN has an average 20-day volume of 1,226 shares, indicating relatively low trading activity. The last price of $24.63 reflects current market valuation. The short-term SMA (20-period) stands at $28.42, while the medium-term SMA (50-period) is at $30.00, and the long-term SMA (200-period) is at $28.93. These moving averages suggest that the ETN is currently below its historical trends. The Average True Range (ATR) of 1.19 indicates moderate volatility in recent trading sessions.

Average Volume 20d: 1226 Last Price: 24.63 SMA 20: 28.42 SMA 50: 30.00 SMA 200: 28.93 ATR: 1.19

The funds assets under management (AUM) total $10.43 million, reflecting its relatively small size in the leveraged equity ETF/ETN space. This smaller AUM may contribute to lower liquidity and potentially higher tracking error compared to larger funds.

AUM: 10.43M USD

Based on the technical and fundamental data, the 3-month outlook for BDCX suggests continued downward pressure, as the ETN is trading below its key moving averages. The 20-period SMA of $28.42 and 50-period SMA of $30.00 act as resistance levels, while the ATR of 1.19 indicates potential volatility. Given the bearish trend and relatively small AUM, BDCX may face challenges in regaining its long-term SMA of $28.93 in the near term. The ETN is likely to remain sensitive to broader market conditions and sector-specific movements in the BDC space.

Additional Sources for BDCX ETF

BDCX ETF Overview

Market Cap in USD 10m
Category Trading--Leveraged Equity
TER 95.00%
IPO / Inception 2020-06-02

BDCX ETF Ratings

Growth Rating 70.1
Fundamental -
Dividend Rating 88.7
Rel. Strength -11.7
Analysts -
Fair Price Momentum 30.36 USD
Fair Price DCF -

BDCX Dividends

Dividend Yield 12m 17.67%
Yield on Cost 5y 40.75%
Annual Growth 5y 21.41%
Payout Consistency 98.7%

BDCX Growth Ratios

Growth Correlation 3m -81.9%
Growth Correlation 12m 31.6%
Growth Correlation 5y 83.3%
CAGR 5y 17.87%
CAGR/Max DD 5y 0.51
Sharpe Ratio 12m 0.12
Alpha -12.29
Beta 0.906
Volatility 41.54%
Current Volume 0.3k
Average Volume 20d 2.3k
What is the price of BDCX stocks?
As of April 26, 2025, the stock is trading at USD 27.20 with a total of 345 shares traded.
Over the past week, the price has changed by +7.81%, over one month by -10.94%, over three months by -12.59% and over the past year by -2.15%.
Is ETRACS Quarterly Pay 1.5X a good stock to buy?
Yes. Based on ValueRay Analyses, ETRACS Quarterly Pay 1.5X (NYSE ARCA:BDCX) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 70.08 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BDCX as of April 2025 is 30.36. This means that BDCX is currently undervalued and has a potential upside of +11.62% (Margin of Safety).
Is BDCX a buy, sell or hold?
ETRACS Quarterly Pay 1.5X has no consensus analysts rating.
What are the forecast for BDCX stock price target?
According to ValueRays Forecast Model, BDCX ETRACS Quarterly Pay 1.5X will be worth about 34.4 in April 2026. The stock is currently trading at 27.20. This means that the stock has a potential upside of +26.29%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 34.4 26.3%